Close
Back to BIIB Stock Lookup

Biogen (BIIB) –

Jul 16, 2024 05:10 AM Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing
Jul 12, 2024 07:22 AM Biogen (BIIB) PT Lowered to $313 at Piper Sandler
Jul 11, 2024 01:32 PM Biogen: RBC says 'very likely' that Leqembi will be approved in Europe
Jul 11, 2024 06:37 AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB), very likely Leqembi will be approved in Europe
Jul 4, 2024 10:20 AM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
Jul 2, 2024 04:02 PM BIIB STOCKHOLDERS: Lead Plaintiff Deadline Approaching in Biogen Inc. Class Action; Contact Robbins LLP
Jul 2, 2024 01:55 PM Biogen (BIIB) trades lower after after Lilly's Alzheimer's drug is approved
Jul 2, 2024 01:55 PM Eli Lilly Alzheimer's drug approved by US FDA
Jul 2, 2024 09:17 AM Biogen (BIIB) Completes Acquisition of Human Immunology Biosciences
Jul 2, 2024 09:16 AM Biogen Completes Acquisition of Human Immunology Biosciences
Jul 1, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, Fastly, and NIKE and Encourages Investors to Contact the Firm
Jul 1, 2024 07:00 AM BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline
Jun 28, 2024 09:40 AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
Jun 27, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, Fastly, and NIKE and Encourages Investors to Contact the Firm
Jun 27, 2024 07:39 PM “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
Jun 26, 2024 03:25 PM RBC Capital on Biogen (BIIB): 'We See An EU Approval In 3Q24 As Likely'
Jun 26, 2024 05:24 AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)
Jun 25, 2024 05:21 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: SHERWIN STEPHEN A
Jun 25, 2024 05:20 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: Mantas Jesus B
Jun 25, 2024 05:18 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: Rowinsky Eric K
Jun 25, 2024 05:17 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: LANGER SUSAN
Jun 25, 2024 05:16 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: Patolawala Monish D
Jun 25, 2024 05:14 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: HAWKINS WILLIAM A
Jun 25, 2024 05:13 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: Freire Maria C
Jun 25, 2024 05:07 PM Form 4 BIOGEN INC. For: Jun 21 Filed by: DORSA CAROLINE
Jun 25, 2024 05:01 PM Form 8-K BIOGEN INC. For: Jun 20
Jun 24, 2024 03:46 PM BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline
Jun 24, 2024 07:30 AM Biogen (BIIB) Announces TOFIDENCE Approved in the EU
Jun 24, 2024 07:30 AM TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
Jun 24, 2024 06:57 AM Biogen (BIIB) PT Raised to $555 at Wells Fargo
Jun 23, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm
Jun 20, 2024 05:08 PM Form S-8 BIOGEN INC.
Jun 19, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm
Jun 17, 2024 07:15 AM BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc.
Jun 15, 2024 06:04 AM BIOGEN STOCK NOTICE: Lose Money on your Biogen Inc. (Nasdaq: BIIB) Investment? BFA Law Encourages You to Contact the Firm before July 22, 2024 Court Deadline
Jun 13, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm
Jun 13, 2024 05:20 PM Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors of Class Action Filing and Encourages Investors to Contact the Firm
Jun 13, 2024 07:31 AM BIOGEN LEGAL DEADLINE: If You Lost Money on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Encouraged to Contact BFA Law Before July 2024 Court Deadline
Jun 12, 2024 10:10 AM Scotiabank Reiterates Sector Outperform Rating on Biogen (BIIB)
Jun 11, 2024 08:45 AM Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
Jun 11, 2024 08:33 AM Eli Lilly inches higher premarket after FDA advisory panel backs Alzheimer's drug
Jun 11, 2024 06:43 AM BIOGEN NOTICE: If You Suffered Losses on Your Biogen Inc. (Nasdaq: BIIB) Investment, You are Reminded to Contact BFA Law Before Approaching July 2024 Legal Deadline
Jun 10, 2024 12:43 PM BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc.
Jun 9, 2024 10:13 PM Eisai, Biogen (BIIB) announced FDA acceptance of sBLA for LEQEMBI IV maintenance dosing
Jun 9, 2024 07:37 PM FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Jun 9, 2024 07:30 PM FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Jun 8, 2024 05:11 AM BIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal Deadline and Encouraged to Contact BFA Law
Jun 7, 2024 05:12 PM BIIB Class Action Reminder: Contact Robbins LLP for Information About Your Rights Against Biogen Inc.
Jun 7, 2024 09:14 AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)
Jun 6, 2024 10:10 AM Stifel Reiterates Buy Rating on Biogen (BIIB)

Back to BIIB Stock Lookup